TP53 and lung carcinoma: The mechanism clarified that TC2N represses p53 transcriptional activity through inhibiting cyclin-dependent kinase 5 (Cdk5)-induced phosphorylation of p53 via inducing Cdk5 degradation or disrupting the interaction between Cdk5 and p53 in lung cancer cells.